ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "autoantibodies"

  • Abstract Number: 1328 • 2014 ACR/ARHP Annual Meeting

    Modulation of Natural IgM-Autoantibodies to Oxidative Stress-Related Neo-Epitopes on Apoptotic Cells in Newborns of Mothers with Anti-Ro Autoimmunity

    Caroline Grönwall1, Robert M. Clancy2, Lelise Getu3, Don L. Siegel4, Joanne Reed3, Jill P. Buyon2 and Gregg J. Silverman1, 1Medicine, New York University School of Medicine, New York, NY, 2Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 3New York University School of Medicine, New York, NY, 4Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose At birth, the human immune system expresses substantial circulating levels of polymeric IgM that include autoantibodies to oxidation-associated epitopes on apoptotic cells. This study…
  • Abstract Number: 773 • 2014 ACR/ARHP Annual Meeting

    Functional Autoantibodies from Patients with Systemic Sclerosis Reactive to Angiotensin II Type 1 and Endothelin-1 Type a Receptor Induce Inflammatory Lymphocyte Infiltration into Lungs of Mice

    Angela Kill1, Clement Braesch1, Anja Kühl2, Jeannine Guenther3, Mike O. Becker4, Gerd Burmester5, Thomas Walther6 and Gabriela Riemekasten7, 1Rheumatology and clinical Immunology, Charité University Hospital, German Rheumatology Research Center, a Leibniz Institute, Berlin, Germany, 2Department of Internal Medicine, Charité University Hospital, Berlin, Germany, 3Rheumatology and Clinical Immunology, Charité University Hospital, German Rheumatology Research Center, a Leibniz Institute, Berlin, Germany, 4Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, 5Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, 6Pharmacology & Therapeutics, University College Cork, Cork, Ireland, 7Charité University Hospital and German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany

    Background/Purpose Functional autoantibodies reactive to the angiotensin II type 1 receptor (AT1R) and endothelin 1 type A receptor (ETAR) were found in elevated levels in…
  • Abstract Number: 2700 • 2014 ACR/ARHP Annual Meeting

    Clinical Phenotype of Systemic Sclerosis Patients with Anti-RNA Polymerase III Antibodies: A New French Cohort, Systematic Review and Meta-Analysis

    Vincent Sobanski1,2, Luc Dauchet3,4, Guillaume Lefèvre2, Marc Lambert5, Sandrine Morell-Dubois6, Thierno Sy6, Eric Hachulla1, Pierre-Yves Hatron7, Sylvain Dubucquoi8,9 and David Launay1,9, 1Service de médecine interne, Centre National de Référence de la Sclérodermie Systémique, Hôpital Claude Huriez, CHRU Lille, Lille, France, 2EA 2686, Lille, LILLE, France, 3Service d'Epidémiologie Régionale, CHRU Lille, LILLE, France, 4INSERM U744, LILLE, France, 5Faculté de Médecine Henri Warembourg, Université Lille Nord de France, Lille, France, 6Internal Medicine, CHRU Lille, LILLE, France, 7Internal Medicine, Lille, France, 8Institut d’Immunologie, Centre de Biologie-Pathologie-Génétique, CHRU Lille, Lille, France, 9EA 2686, Lille, Lille, France

    Background/Purpose: Anti-RNA polymerase III antibodies (anti-RNAP III) are one of the most frequent antinuclear antibodies identified in systemic sclerosis (SSc), with an estimated prevalence of…
  • Abstract Number: 1317 • 2014 ACR/ARHP Annual Meeting

    Anti-p155/140 Autoantibodies and Selected Features at Illness Onset Are Associated with a Chronic Course of Illness in the Juvenile Idiopathic Inflammatory Myopathies

    G. Esther A. Habers1, Adam M. Huber2, Gulnara Mamyrova3, Ira Targoff4, Chantal Boonacker5, Marco van Brussel1, Frederick W. Miller6, Lisa G. Rider6 and Annet van Royen-Kerkhof7, 1Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands, 2IWK Health Centre, Halifax, NS, Canada, 3Rheumatology, George Washington University, Washington, DC, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands, 6Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, 7Paediatric Immunology and Rheumatology, University Medical Centre Utrecht - Wilhelmina Children's Hospital, Utrecht, Netherlands

    Background/Purpose : Three types of disease courses can be distinguished in patients with juvenile idiopathic inflammatory myopathies (JIIM), namely monocyclic (M), polycyclic (P), and chronic…
  • Abstract Number: 761 • 2014 ACR/ARHP Annual Meeting

    Specific Autoantibody Profiles and Disease Subgroups Correlate with Circulating Micro-RNA in Systemic Sclerosis

    Dirk Wuttge1, Anting L. Carlsen2, Gabriel Teku3, Samantha Steen4, Marie Wildt1, Mauno Vihinen3, Roger Hesselstrand1 and Niels H. H. Heegaard4,5, 1Rheumatology, Lund University, Lund, Sweden, 2Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen, Denmark, 3Experimental Medical Science, Lund University, Lund, Sweden, 4Department of Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen, Denmark, 5Department of Clinical Biochemistry & Pharmacology, Odense University Hospital, Odense C, Denmark

    Background/Purpose: Systemic sclerosis (SSc) is a serious autoimmune disease with clinical phenotypes of different prognosis, progression rate, and different extent of involvement of internal organs.…
  • Abstract Number: 2407 • 2013 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis-Related Autoantibodies In The Lung Evolve Over Time In Subjects At Elevated Risk For Future Rheumatoid Arthritis

    M. Kristen Demoruelle1, Patrick R. Wood2, Michael H. Weisman3, Mark C. Parish1, Isabel F. Pedraza4, Jill M. Norris5, V. Michael Holers6 and Kevin D. Deane1, 1Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 2Internal Medicine, University of Colorado School of Medicine, Aurora, CO, 3Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 4Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 5Epidemiology, Colorado School of Public Health, Aurora, CO, 6Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Recent data from our group have demonstrated that RA-related autoantibodies (Abs), including anti-CCP and RF, are detectable in sputum from subjects with early Classified…
  • Abstract Number: 1600 • 2013 ACR/ARHP Annual Meeting

    Anti-Ribosomal P Protein Antibodies Exacerbate Long-Term Prognosis In Patients With Diffuse Neuropsychiatric/Neuropsychological Syndromes In Systemic Lupus Erythematous

    Yoshiyuki Arinuma1, Hirotoshi Kikuchi2, Eisuke Ogawa1, Tatsuhiko Wada1, Tatsuo Nagai3, Sumiaki Tanaka1 and Shunsei Hirohata1, 1Int Med/Rheumatol & Infec Dis, Kitasato University School of Medicine, Sagamihara, Japan, 2Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 3Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan

    Background/Purpose:  Systemic lupus erythematous (SLE) is a chronic inflammatory disease characterized by the expression of a variety of autoantibodies. Although the comprehensive survival from the…
  • Abstract Number: 560 • 2013 ACR/ARHP Annual Meeting

    Purified IgG From Patients With Systemic Lupus Erythematosus Enhances Apoptosis In Neonatal Rat Cardiomyocytes Exposed To Simulated Myocardial Ischaemic/Reperfusion Injury

    Lauren Bourke1, James McCormick2, Vera Ripoll3, Charis Pericleous4, Anna Radziszewska5, Anastasis Stephanou6 and Yiannis Ioannou7, 1Centre for Rheumatology Research, University College London, London, United Kingdom, 2Clinical & Molecular Genetics Unit, University College London, London, United Kingdom, 3Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom, 4Centre for Rheumatology, Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom, 5The Rayne Institute, Arthritis Research UK Centre for Adolescent Rheumatology at University College London, Great Ormond Street Hospital and UCLH, University College London, London, United Kingdom, 6Medical and Molecular Biology Unit (MMBU), University College London, London, United Kingdom, 7Arthritis Research UK Centre for Adolescent Rheumatology at University College London, Great Ormond Street Hospital and UCLH, University College London, London, United Kingdom

    Background/Purpose: A significant amount of myocardial damage during a myocardial infarction (MI) occurs during the reperfusion stage which is known as ischaemic reperfusion (I/R) injury…
  • Abstract Number: 2289 • 2013 ACR/ARHP Annual Meeting

    Correlation Of Anti-Citrullinated Protein and Anti-Carp Antibodies With Disease Duration and Activity In Rheumatoid Arthritis

    Michael Mahler1, Gabriella Lakos1, Tyler Webb1, Alvin Yee1, Leendert A. Trouw2 and Pier-Luigi Meroni3, 1Research, INOVA Diagnostics, San Diego, CA, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Int Medicine, University of Milan, Milano, Italy

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are important serological markers in the diagnosis of rheumatoid arthritis (RA) and are part of the…
  • Abstract Number: 1602 • 2013 ACR/ARHP Annual Meeting

    Autoantibodies, Cytokines and Chemokines In Serum and Cerebrospinal Fluid Of SLE Patients With Cognitive Dysfunction

    Hilda Fragoso-Loyo1, Alí Duarte-García2, Sandra Juárez-Arellano3, Alba Cicero-Casarrubias4, Juanita Romero-Díaz5, Luis LLorente-Peters1 and Jorge Sánchez-Guerrero6, 1Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 2Department of Medicine, Tufts Medical Center, Boston, MA, 3Department of Neurology, Instituto Nacional de Ciencias Medicas y Nutricion S.Z., Mexico city, Mexico, 4Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 5Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico, 6Rheumatology, Mount Sinai Hospital and University Health Network, Toronto Canada, Toronto, ON, Canada

    Background/Purpose: The nature and pathogenesis and cognitive dysfunction (CD) in patients with SLE is unkown.To determine the presence and levels of autoantibodies, cytokines and chemokines…
  • Abstract Number: 527 • 2013 ACR/ARHP Annual Meeting

    Presence Of Gastrointestinal Symptoms and Autoantibodies In Patients With Spondyloarthritis In A Colombian Population

    Consuelo Romero-Sanchez1,2,3, Wilson Bautista-Molano1,4, Diana M Munoz C1, Viviana Parra I1, Alejandro Escobar1, Carlos Martínez5, Ferney Garcia5, Daniel Herrera6, Sebastían Segura1, Juliette De Ávila3, Ana MAría Mesa1, Haroldo Juliao7, John Londono1 and Rafael Valle-Oñate8,9, 1Rheumatology, Spondyloarthropathy Group, Rheumatology Department, Hospital Militar Central/Universidad de La Sabana, Bogotá, Colombia, 2Rheumatology, Universidad Militar Nueva Granada, Bogotá, Colombia, 3School of Dentistry, UIBO Institute (Oral Basic Research Unit),School of Dentistry, Universidad El Bosque, Bogotá, Colombia, 4Universidad Militar Nueva Granada, Bogotá, Colombia, 5Coloproctology, Coloproctology Deparment, Hospital Militar Central, Bogotá, Colombia, 6Genetic, Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia, 7Gastroenterology, Gastroenterology Deparment, Hospital Militar Central, Bogotá, Colombia, 8Spondyloarthritis Group. Rheumatology Department. Hospital Militar Central/Universidad de La Sabana. Bogotá. Colombia, Bogotá, Colombia, 9Rheumatology, Faculty of Medicine, Universidad Militar Nueva Granada, Bogotá, Colombia

    Background/Purpose: The frequency of gastrointestinal (GI) involvement in spondyloarthritis (SpA) ranges from 21% to 30% and 5% to 10% are associated with inflammatory bowel disease…
  • Abstract Number: 2217 • 2013 ACR/ARHP Annual Meeting

    Experimental Arthritis Exacerbates Periodontal Disease But Periodontal Infection Does Not Exacerbated Experimental Arthritis

    John Butcher1, Jessica Oliver-Bell1, Robert Benson1, James Brewer2, Paul Garside1, Iain B. McInnes1 and Shauna Culshaw3, 1Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 2Immunology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 3Dental School, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: There is a proposed link between periodontal disease (PD) and rheumatoid arthritis (RA). A substantial, although not unanimous, body of epidemiological evidence indicates a…
  • Abstract Number: 1575 • 2013 ACR/ARHP Annual Meeting

    Identification Of Novel Distinct Autoantigen Clusters Reflecting The Heterogeneity Of Systemic Lupus Erythematosus

    Petra Budde1, Angelika Lueking1, Stefan Vordenbäumen2, Heike Göhler1, Martin Gamer1, Klaus Marquardt1, Anna Telaar1, Daniel Chamrad1, Carmen Theek1, Peter Schulz-Knappe1 and Matthias Schneider2, 1Protagen AG, Dortmund, Germany, 2Department of Endocrinology, Diabetes and Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany

    Background/Purpose: Diagnosis of systemic lupus erythematosus (SLE) is based on a combination of clinical findings and laboratory evidence such as anti-nuclear autoantibodies (ANA), anti-Smith and…
  • Abstract Number: 541 • 2013 ACR/ARHP Annual Meeting

    An Essential Role For Caspase-1 In The Induction Of Murine Lupus and Its Associated Vascular Damage

    J. Michelle Kahlenberg1, Srilakshmi Yalavarthi2, Wenpu Zhao2, Jeffrey Hodgin3, Tamra J. Reed4, Noriko M. Tsuji5 and Mariana J. Kaplan6, 1Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2University of Michigan Rheumatology, Ann Arbor, MI, 3Department of Pathology, University of Michigan, Ann Arbor, MI, 4Internal Medicine, Rheumatology, University of Michigan, Ann Arbor, MI, 53Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan, 6Systemic Autoimmunity Branch, National Institutes of Health/NIAMS, Bethesda, MD

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a systemic autoimmune syndrome associated with organ damage and an elevated risk of cardiovascular disease (CVD) resulting from activation…
  • Abstract Number: 2070 • 2013 ACR/ARHP Annual Meeting

    Cytokine Profiles In Polymyositis and Dermatomyositis Complicated With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Associated Interstitial Lung Disease Or Anti-Aminoacyl tRNA Synthetase Antibody-Associated Interstitial Lung Disease

    Takahisa Gono, Yasushi Kawaguchi, Hirotaka Kaneko, Yasuhiro Katsumata, Masanori Hanaoka, Sayuri Kataoka, Hidenaga Kawasumi, Kae Takagi, Hisae Ichida, Sayumi Baba, Yuko Okamoto, Yuko Ota and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: Polymyositis (PM) / dermatomyositis (DM) are often complicated with interstitial lung disease (ILD). In PM/DM, complication with ILD is associated with anti-aminoacyl-tRNA synthetase (ARS),…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 28
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology